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The effects of socioeconomic development
on worldwide hepatitis A virus
seroprevalence patterns
KH Jacobsen1,2* and JS Koopman1

1 March 2005

Background Hepatitis A virus (HAV) infection confers long-term immunity, so mathematical
analysis of age-specific seroprevalence in populations can reveal changes in the
infection rate over time. HAV transmission is related to access to clean drinking
water, personal hygiene and public sanitation.
Methods

We used an SIR (susceptible-infectious-recovered) compartmental model with
age structure to fit a time-dependent logistic function for HAV force of infection
for 157 published age-seroprevalence data sets. We then fit linear regression
models for socioeconomic variables and infection rate.

Results

The proportion of the population with access to clean drinking water, the value
of the human development index (HDI), and per capita gross domestic product
(GDP) are all inverse predictors of HAV infection rates. Declining infection rates
were observed in 65.6% of the surveys.

Discussion

This work demonstrates the utility of HAV seroprevalence studies to reveal
patterns of change in force of infection and to assess the association between
socioeconomic risk factors and transmission rates.

Keywords
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Hepatitis A virus (HAV) infection is a common infection,
responsible for about 1.4 million new infections worldwide each
year.1 Infection is generally acquired by the faecal–oral route
either through person-to-person contact or ingestion of
contaminated food or water.2 Low income, low educational
level, crowding and lack of access to safe drinking water and
sanitation facilities are associated with increased HAV infection.3
As socioeconomic status (SES) and access to safe drinking water
are increasing, the HAV infection rate is declining in most parts
of the world.3 However, because HAV infection in children is
often asymptomatic but most infected adults present with
jaundice and other potentially severe symptoms, this decrease in
the infection rate has a paradoxical effect. As socioeconomic
conditions improve, individuals become infected at a later age
when disease is more severe. Thus, hepatitis A morbidity may
increase as the incidence rate of infection decreases.
Population age-immunity structure is important in predicting
HAV transmission patterns. In areas with very high endemicity,
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30–40% of children acquire infection before 5 years of age
and almost all persons have been infected by early adulthood.1
In these regions there is very little hepatitis A disease. In areas
with low endemicity, few children have anti-HAV antibodies,
and many adults remain susceptible. Epidemics are uncommon
in highly endemic areas because most adults have acquired
immunity but in regions with lower levels of adult immunity
HAV infections may occur primarily as outbreaks.4
Because infection with HAV generally confers lifelong
immunity to all strains of HAV, age-specific seroprevalence rates
are indicators of the level of susceptibility to severe disease in a
population. Furthermore, the shapes of population ageseroprevalence curves reflect the changes in force of infection
that have occurred over the lifetimes of the people in the
populations (Figure 1). For example, in a population that had a
high infection rate until 40 years ago and then experienced a
rapid increase in SES and access to improved water sources, the
population seroprevalence curve would show that nearly all
adults 40 years have antibodies while few persons 40 years
of age have immunity. A population with a more gradual
decline in the infection rate over time would have a rounder
age-seroprevalence curve. A population with a consistently
high force of infection would have a steep rise in seroprevalence
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in young children. Thus, it is possible to use data about ageseroprevalence distributions in real populations to determine
both when changes in the infection rate occurred and the rate
of change over time.
In this paper we use a deterministic model to calculate timedependent infection rates for 157 sets of age-seroprevalence
data from surveys conducted across the globe. We assess
regional differences in infection rates and the trend of declining
infection rates seen in most regions of the world. We also use
linear regression to examine measures of socioeconomic
development which might be related to changes in the infection
rate over time.

Mathematical model
We formulated a mathematical model that represents the
transmission dynamics for populations with various age and
immunity structures. An SIR (susceptible-infectious-recovered)
compartmental model with 80 age groups (one-year age
compartments for ages 1–80) was used. We assumed that
infants entered the population at 1 year of age, when maternal
immunity had waned, and all adults were removed from the
population before age 81. The distribution of the population by
age was estimated using international data from the US Census

Bureau,5 and age-specific death rates were calculated to
maintain population size and age-structure.
A flow diagram of the model, which consists of ordinary
differential equations, and definitions of model parameters are
shown in Figure 2. The equations used are as follows:
dSi/dt  aSi

1

dIi/dt  aIi 1Si

where S is the proportion of susceptible persons, I is the
proportion of infectious persons, and R is the proportion of
immune (recovered) persons in the total population. The
subscript i indicates age-specific values, a represents aging, µi is
the age-specific death rate, ρ is the recovery rate, and λ is the
infection rate. For the first age group a birth function, rather
than an aging function, was used to add susceptible one-yearolds to the population.
This model structure requires a number of key assumptions.
(i) All persons in the population are susceptible to infection
until they become infected. (ii) Infection produces lifelong
immunity, which can be detected by serological examination.
(iii) Mortality due to infection is negligible. (iv) Populations are
homogeneous with respect to susceptibility and exposure. (v)
The samples consist of individuals who have spent their entire
lives in the same population. This assumes, for instance, that
members of low-endemicity populations have not travelled to
endemic areas. (vi) The immunization rate is very low such that
we can assume that immunity is the result of infection and not
immunization.
We used a three-parameter symmetric logistic function to
describe the infection rate λ over time:

Si

λSi


1

t

where λ∞ is the constant representing the asymptote of the past
force of infection, θ and α are constants, 0  θ  1, and
0  α  ∞. We set t = 0 as the time 100 years before the
collection of data. We assumed that the initial population had
very high seroprevalence, with all children acquiring immunity
in early childhood. The conclusions of the model were not
sensitive to the assumption of very high endemicity at the start
of the run because the model was run long enough to replace
the entire population.
The value of the infection rate, λ, in a given time period (set
as one month) determined the proportion of susceptible persons

Figure 1 Sample age-seroprevalence curves: (a) high rate of
transmission, (b) gradual decrease in force of infection and (c) rapid
decrease in force of infection
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Figure 2 Model of population transmission dynamics. S, the proportion of susceptible persons in the total population; I, the proportion of
infectious persons in the total population; R, the proportion of immune (recovered) persons in the total population; Ni, the proportion of the total
population of age i, where 1  i  80; a, rate of aging from age i to age i + 1; µi, death rate for age i; λ, infection rate; ρ, recovery rate (end of
infectious stage). In this model we assumed that recovery from the infectious stage occurred after an average of 3 months
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in the model population who acquired new infections during
that time period. The rate and magnitude of change in λ during
the 100 years the model was run defined the shape of the ageseroprevalence curves. The infection rate over time, λ(t), was
described by λ∞, θ and α.
For each of the 157 data sets we analysed, we used Berkeley
Madonna software to fit the values of λ∞, θ and α that generated
age-seroprevalence curves that most closely matched the actual
data. These values were fit by writing a least squares function for
each dataset. The equation of the optimizing function was:

Table 1 Location of included studies, by region
Region

Countries

Africa (n = 7)

Cameroon
Dem. Rep. Congo
Ethiopia
Senegal
Sierra Leone
South Africa (2)

Americas (n = 31)
k
j1mj(p̂j

Belize

pj)2



Bolivia (3)

k
j1mj

where p̂ was the reported fraction of a particular age group
with anti-HAV antibodies from the literature, p was the
seroprevalence for that age group generated by the computer,
and m was the age range in each of the k number of age groups
j. The optimizing function minimized the average difference
between observed seroprevalence rates and the corresponding
seroprevalence rates generated by the computer for each age or
age group.
Each model was run for 100 years, ending at the time of data
collection, and the calculated infection rate at the time of data
collection was recorded. Age-group seroprevalence rates for
model populations, such as the proportion of adults aged 30
with immunity, were calculated from the one-year age
compartments. We also calculated the derivative of the equation for the infection rate so that we could find both the slope
of the change in λ over time and the time when the decrease in
λ was most rapid:
(t)’ 

Brazil (10)
Canada (3)
Chile (2)
Costa Rica
Dominican Republic
Jamaica
Mexico
Peru
Uruguay (2)
USA
Venezuela (2)
Asia (n = 40)

Australia (2)
China (9)
Hong Kong (2)
India (6)
Indonesia (2)

 t(ln )
( t  )2

Japan (8)
Korea

Data collection

Malaysia

Seroprevalence data
An extensive search of the hepatitis literature identified 172
reports of anti-HAV seroprevalence by age group. From the
analysis, 15 small datasets, defined as averaging 5 persons per
age within the age range covered by the study, were removed.
The remaining 157 datasets (Table 1) included 7 studies from
sub-Saharan Africa,6–12 31 from the Americas,13–36 40 from Asia
and the Pacific,37–62 62 from Europe63–108 and 17 from the
Middle East and North Africa.109–124
For our sample data we assumed that reported seroprevalence rates provide a correct measure of population immunity
and that the sample population was representative of the source
population. In particular, we assumed that the distribution of
study participants by age within reported age groups reflected
the actual distribution by age of the source population and that
the sample population was not skewed towards the young or
old within each age group.

Nepal

Water data
The United Nations’ estimates of the percentage of each nation’s
population with access to improved water in 1980, 1990 and
2000, or as many years as were reported, were collected.125 A
line was fit through these points and used to estimate the level
of water coverage for each study at the time of data collection.

Singapore
Sri Lanka
Thailand (5)
Vietnam
Europe (n = 62)

Austria (2)
Belgium (2)
Czech Republic
Denmark
France
Germany (4)
Greece (5)
Greenland
Iceland (2)
Italy (13)
Netherlands (2)
Poland (4)
Portugal (2)
San Marino
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Table 1 continued
Region
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0.08

Countries

0.07

Sweden (3)
Switzerland
United Kingdom (3)
Middle East (n = 17)

Algeria

Force of Infection

Spain (14)

Iran

0.06
Vietnam
Bolivia

0.05
0.04

Brazil
Venezuela
Turkey

0.03
0.02

Lebanon
0.01

Morocco
1960

Saudi Arabia (6)

1980

2000

Year

Syria

0.01

Turkey (5)

0.009

Socioeconomic data
The Human Development Index (HDI) calculated by the United
Nations Development Programme (UNDP) incorporates data on
life expectancy, education and standard of living [gross domestic
product (GDP)] into an index number. The HDI for each nation
in 1975, 1980, 1985, 1990, 1995 and 2001, or as many years as
were reported, were collected and a linear fit used to estimate
HDI for each study year.126 Data for four surveys were
unavailable. We also collected the United Nations estimates of
the per capita GDP in current international dollar purchasing
power parity (PPP) for 1986, 1990 and 2000, or as many years
as were reported.127 A line was fit through these points and
used to estimate GDP per capita for each study at the time of
data collection. Data for 17 surveys were unavailable.
Linear regression was used to fit models for predicting
the infection rate at the time of data collection. Predictor variables
included the proportion of the population with access to clean
water, HDI, per capita GDP and survey year. Simple and multiple
regressions, with and without interaction terms, were fit.

0.007
Turkey
Poland

0.006
0.005

CzechRep.
UK
Sweden

0.004
0.003
0.002
0.001
0
1940

1960

1980

2000

Year

Figure 3 Sample force of infection plots at the time of data collection
for selected countries.24,27,30,72,75,96,113,118,133

1

Prevalence of anti-HAV

When study populations were clearly identified as urban or
rural, an urban- and rural-specific water coverage estimate was
also recorded. When data on water coverage for high-income
nations (Europe, United States, Canada, Australia and Japan)
were missing, we assumed that those nations had 100% water
coverage. Data for six of the surveys conducted in low-income
areas were not available.

Force of Infection

0.008

0.8

Vietnam (1999)
Bolivia (1997)
Brazil (2002)
Venezuela (1996)
Turkey (2001)
Poland (1997)
CzechRep. (1996)
UK (1996)
Sweden (1991)

0.6

0.4

0.2

0
0

20

40

60

80

Age (Years)

Results
Force of infection plots (Figure 3) and their corresponding ageseroprevalence curves (Figure 4) were obtained for 157 datasets
using the techniques described in the Methods section.
A crude value for the average annual infection rate in each
region was calculated by taking the mean infection rate of all
the studies from that region (Table 2). Average annual infection
rates were highest in Africa (0.60, or 600 infections per 1000
susceptible persons per year), followed by the Americas (0.34),
the Middle East (0.22), and Asia (0.21). Rates in Europe (0.01,
or 10 infections per 1000 susceptible persons per year) were the
lowest of any region.

Figure 4 Corresponding age-seroprevalence curves at the time of data
collection for selected countries.24,27,30,72,75,96,113,118,133

The ability of water and two measures of socioeconomic
development to predict infection rates was assessed using simple
linear regression (Table 3). The estimated percentage of the
population with access to an improved water source, as defined
by the United Nations, is a significant predictor of the force of
infection (r2 = 0.37) (Figure 5). A correlation for region-specific
mean water coverage rates and mean forces of infection showed
a very strong correlation (r2 = 0.98) (Figure 6).
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Table 2 Regional statistics for force of infection
Total

Africa

Americas

Asia

Europe

157

7

31

40

62

17

0.18 ± 0.41

0.60 ± 0.24

0.34 ± 0.74

0.21 ± 0.37

0.01 ± 0.02

0.22 ± 0.24

Number of surveys
Average infection rate (at time
of data collection) (mean ± SD)

Middle East

Surveys from 1990 and later (n = 83)

0.19 ± 0.36

0.49 ± 0.25

0.25 ± 0.44

0.31 ± 0.45

0.01 ± 0.01

0.21 ± 0.30

Surveys from before 1990 (n = 74)

0.16 ± 0.47

0.62 ± 0.22

0.68 ± 1.35

0.11 ± 0.22

0.02 ± 0.03

0.23 ± 0.19

Studies with decreasing
force of infection (%)

66

0

42

57

97

41

Mean % of susceptible adults
(ages 30–80)

13

0

7

8

24

3

Water

HDI

GDP

Year

Total

Africa/
Middle East

Americas

Asia

Europe

r2 = 0.37

r2 = 0.24

r2 = 0.60

r2 = 0.08

r2 = NA

P  0.0001

P = 0.032

P  0.0001

P = 0.075

P = NA

n = 151

n = 19

n = 30

n = 40

n = 62

r2 = 0.26

r2 = 0.48

r2 = 0.30

r2 = 0.33

r2 = 0.21

P  0.0001

P = 0.0003

P = 0.001

P = 0.0001

P = 0.0002

n = 153

n = 23

n = 31

n = 39

n = 60

r2 = 0.13

r2 = 0.52

r2 = 0.08

r2 = 0.12

r2 = 0.08

P  0.0001

P = 0.0003

P = 0.133

P = 0.052

P = 0.038

n = 140

n = 21

n = 31

n = 33

n = 55

r2 = 0.01

r2 = 0.08

r2 = 0.01

r2 = 0.11

r2 = 0.12

P = 0.137

P = 0.192

P = 0.656

P = 0.035

P = 0.005

n = 157

n = 24

n = 31

n = 40

n = 62

Figure 5 Water Coverage vs Force of Infection (r2 = 0.37). Each point
represents one of the 157 studies included in this analysis. Infection
rates were calculated from age-seroprevalence data using our
mathematical model. Water coverage data is from the UN [124]

The HDI and per capita GDP are also significant independent
predictors of infection rate (Table 3). When variables for both
water coverage and HDI are included in the model, both water
(P  0.0001) and HDI (P = 0.038) are significant predictors
(r2 = 0.39). When variables for both water coverage and GDP
are included in the total model, water remains a significant

Figure 6 Correlation for Regional Means (r2 = 0.985). Mean water
coverage is the estimated proportion of each region’s population with
access to safe drinking water. The estimates for regional infection rates
were calculated by taking the mean of the infection rates calculated for
studies in each region

variable (P  0.0001) and the correlation increases to r2 = 0.42,
although GDP is not significant (P = 0.354).
Study year is an independent predictor of infection rate for
both Europe (r2 = 0.12, P = 0.005) and Asia (r2 = 0.11,
P = 0.035), where water coverage rates in high-income nations
have not changed significantly over the survey years. In most

Downloaded from https://academic.oup.com/ije/article/34/3/600/682307 by Calvin University user on 07 June 2022

Table 3 Linear correlation for force of infection

SOCIOECONOMIC DEVELOPMENT AND HEPATITIS A VIRUS

Discussion
We used a symmetric logistic function to fit a time-dependent
infection rate for 157 age-seroprevalence datasets. We found
evidence that HAV infection rates are decreasing in most regions
of the world and that water development is crucial in reducing
transmission rates. This work demonstrates the utility of HAV
seroprevalence studies in revealing patterns of change in force
of infection and in assessing the association between
socioeconomic risk factors and transmission rates.
A number of previous studies have calculated HAV infection
rates using seroprevalence data and symmetric logistic
functions,49,91,128,129 a least squares parametric survival
model,130 a stochastic Markov chain model39 and a binomial
likelihood function.131 Others have assessed the effect of
decreases in the basic reproduction number, R0, on the shape of
age-seroprevalence plots.132,133 No previously published works
have evaluated more than eight forces of infection or compared
data from across the globe.
Caution must be used when interpreting the results of our
correlations because studies were selected for inclusion based on
availability and sample size, rather than on demographic or
geographic representativeness. Within each region, certain
countries were overrepresented while data from the majority of
countries were not included (Table 1). Within each nation, the
populations included in our sample may not have been
representative of the total national population with regard to SES,
urban or rural residence, water coverage or age structure. Missing
data on sample size may have led to the inclusion of some surveys
that did not meet the selection criteria and limited reporting of

urban/rural status may have caused errors in the water coverage
estimates. The estimate of regional infection rates did not account
for variations in sample size or quality among included studies.
Studies at the local level have found evidence of an
association between type of water source and water storage, the
quantity and quality of water available, the reliability of water
treatment and sanitation facilities and the number of taps in the
home in addition to income, crowding, family size and
education.3 Water improvements are closely related to other
aspects of socioeconomic development, including decreased
crowding, increased education and increased income, so it is
difficult to separate out the effects of water access from
economic growth. Regardless, the higher correlation between
water and infection rate indicates that access to clean water may
be very important in reducing HAV transmission. We believe
that more accurate information on water coverage levels for the
surveys included in our sample, such as data for the state or
provincial level rather than the national level, would probably
yield a higher correlation between higher water coverage and
lower infection rates. For example, several of the studies
included in our analysis indicated that their study site was rural
or urban. Using the United Nations’ urban- or rural-specific
estimates of water coverage rather than the total estimate of
water coverage improved the fit of the models, although we did
not include this information in our Results section because few
studies could be classified by population density.
Determining the mechanism by which water improvements
cause a decrease in transmission is challenging. Declining
transmission could result from improved hygiene practices
(which reduce direct transmission), better sanitation (which
reduces waterborne transmission) or a combination of hygiene
and sanitation. The separate effects of increased water quantity
and improved water quality are also difficult to distinguish.
Increased quantity allows more water for washing and cleaning
and a decreased need for water storage, which is associated with
increased HAV infection risk.3 Increased quality directly decreases
risk of disease transmission because of a reduction in the
ingestion of the virus in water. Further studies of the mechanisms
for water-related transmission of HAV would improve both our
understanding of the factors that lead to decreasing transmission
and our ability to model the various modes of transmission of
HAV. Serological data will be tremendously useful in developing
more detailed studies of transmission.
More detailed information on the changes in SES over time
would also improve our model. We focused on the relationship
of water, SES, average GDP and force of infection at the time of
data collection so as to minimize the error that could be
introduced by using water and socioeconomic data collected
at different times using different methods and standards. We,
therefore, did not fully explore the information on past
infection rates provided by the model. In particular, our analysis
of the experience of older persons in the population in this
paper was limited since the immunity of older adults is probably
more reflective of their exposure experience in the distant past
than in the recent past.
Given that HAV has multiple modes of transmission, safe
drinking water does not eliminate risk of infection. We observed
that even in areas with 100% water coverage, the infection rate
is decreasing over time. One limitation of the force of infection
model we used is that it is unable to fit infection rates for
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nations with complete water coverage and relatively low forces of
infection, the infection rate has continued to decrease over time.
To assess possible co-effects of SES, water coverage and study
year, interaction terms were added to the model. None of the
interaction terms are significant predictors of the infection rate.
Declining infection rates were observed in 65.6% of the surveys
(Table 2). None of the studies from Africa showed a decrease in
infection rate whereas nearly all of the studies from Europe (97%)
did. About half the studies from the Middle East (41%), the
Americas (42%) and Asia (57%) indicated decreases in force of
infection. An analysis of the factors that predict a decreasing
infection rate, regardless of the value of the infection rate at the
time of data collection, showed that higher values for HDI, per
capita GDP and water coverage are strongly associated with a
declining infection rate. Of the surveys 80% showing decreasing
infection rates were from nations reporting complete water
coverage. The mean water coverage rate was 80% for surveys
indicating no decline compared with 97% for surveys showing a
decline. Mean HDI values were 0.65 and 0.83, respectively.
Although surveys that showed no decrease in the infection rate
were found for the entire range of values for water coverage and
HDI, a decline in infection rate was seen only in surveys from areas
with an HDI value 0.58 or a water coverage rate 55%.
The proportion of adults aged 30 without immunity to HAV,
an indication of the risk of severe hepatitis A disease, ranged
from 0% in Africa to nearly 24% in Europe. The proportion of
susceptible adults in surveys showing a decreasing infection rate
was 18% compared with only 4% in surveys showing no
decrease.
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over time, a force of infection curve was fit to each individual
dataset. The information provided by each is valid if
independence is assumed.
This analysis of HAV seroprevalence has revealed important
patterns about regional risk factors for transmission. Water and
socioeconomic development are associated with decreasing
infection rates and increasing adult susceptibility levels. In
Africa, where transmission is highly endemic, the provision of
clean water for both drinking and hygiene is a priority for
disease control. Developed countries in Europe, North America
and other parts of the world may be rapidly increasing their
potential for epidemics as the proportion of individuals
susceptible to HAV infection increases. Targeted vaccination for
high-risk groups should be considered in these populations.2 In
the transition economies of Asia, Latin America and the Middle
East, infection rates are beginning to decrease. The gradient of
the decline, whether rapid or gradual, may determine if HAV
transmission remains endemic or shifts to epidemic patterns. In
this paper we have demonstrated that HAV serology provides
an excellent tool for assessing infection rates in populations.
Studies that sample different risk groups by water quality,
economic status and/or sanitary conditions and gather lifetime
histories of exposure should be able to further elucidate risk
factors for transmission.

KEY MESSAGES
•

Seroprevalence by age data can be used to calculate the hepatitis A virus (HAV) infection rate over time.

•

Mathematical models indicate that HAV infection rates are declining in most regions of the world.

•

Hepatitis A virus infection rate is correlated with access to clean drinking water and socioeconomic indicators.
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